Resistance training has been the underweighted half of the exercise-and-brain literature for decades. The aerobic-fitness data are stronger and longer, but a growing body of work shows independent cognitive benefit from resistance training — particularly for executive function — and the mechanistic case has matured. Muscle is now understood as an endocrine organ that secretes myokines (irisin, BDNF, cathepsin B, IL-6 from muscle, others) which cross the blood-brain barrier and engage cognitive pathways. The clinical implication is that strength training is not just for the muscles; it is a brain intervention with measurable cognitive effects and, in older adults, substantial impact on fall risk, sarcopenia, and functional independence.
The cognitive evidence supports independent benefit beyond aerobic exercise. The SMART (Study of Mental and Resistance Training) trial in older adults with mild cognitive impairment showed that resistance training preserved hippocampal subfield volume and improved executive function compared with controls, with effects detectable two years after intervention completion. The combined-modality approach (aerobic plus resistance) produces broader benefits than either alone in most trials, but resistance training carries its own signal — executive function gains, hippocampal preservation, and reductions in subjective cognitive complaints. The patient who is doing aerobic work but no resistance training is missing the second half of the prescription.
The myokine pathway is the most mechanistically illuminating development. Contracting muscle releases dozens of signaling molecules; several of these — particularly irisin and cathepsin B — have been shown in animal and emerging human studies to cross into the brain and stimulate BDNF production in the hippocampus. The muscle-brain axis turns out to be bidirectional and substantial. Sarcopenia (age-related muscle loss) is therefore not just a strength and function problem; it is a loss of an endocrine organ that signals to the brain. The patient with progressive muscle loss is losing a brain input as well as physical capacity.
Resistance training also drives the metabolic and endocrine system that protects cognition. Greater muscle mass improves insulin sensitivity, glucose disposal, and metabolic flexibility — each independently associated with cognitive trajectory. IGF-1 elevation from resistance training supports neuroplasticity. Bone density, autonomic regulation, and inflammation profiles all improve with consistent resistance work. The longevity-psychiatry frame integrates these: a 75-year-old with adequate strength and muscle mass has a fundamentally different metabolic and endocrine substrate than one with sarcopenia, and the cognitive trajectories diverge accordingly.
The prescription is specific and accessible. Two sessions weekly, 30–45 minutes each, covering major muscle groups (legs, hips, back, chest, shoulders, arms) with compound movements (squat, hinge, press, pull, carry patterns). Bodyweight versions work for beginners and frail patients; progressive loading with dumbbells, kettlebells, machines, or bands once movement quality is established. Two to three sets per exercise, 8–12 repetitions per set, progressing in load or volume over months. The dose-response is steep at the low end — even one session weekly produces measurable benefit in previously sedentary adults — and continues with consistent training for years.
The barriers in older adults are real but mostly addressable. Fear of injury, joint pain, lack of access to equipment or gym, lack of instruction, and the cultural assumption that strength training is for younger people each play a role. Physical therapy referral for older adults starting resistance work is often the right entry point — supervised initial sessions establish movement quality, build confidence, and substantially reduce injury risk. Many YMCAs, senior centers, and community gyms have well-designed older-adult strength programs that combine instruction with social engagement. The clinical move is to write the prescription with specificity, address the access barrier, and treat resistance training as the brain intervention that it is. The patient on aerobic exercise but no resistance work is on half the prescription.